During the past decade, Hospital Txagorritxu conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Txagorritxu" #1 sponsor was "PETHEMA Foundation" with 17 trials, followed by "Basque Health Service" with 5 trials sponsored, "Celgene" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Fresenius Medical Care Deutschland GmbH" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Txagorritxu" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Dynamic Science S.L." with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Txagorritxu" are "Multiple Myeloma" (7 trials), "Chronic Hepatitis C" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials), "Acute Promyelocytic Leukemia" (2 trials) and "Chronic Obstructive Pulmonary Disease" (2 trials). Many other conditions were trialed in "Hospital Txagorritxu" in a lesser frequency.

Most popular intervention types in "Hospital Txagorritxu" are "Drug" (33 trials), "Other" (7 trials), "Procedure" (4 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (4 trials), "Placebo" (4 trials), "Melphalan" (3 trials), "Prednisone" (3 trials) and "ATRA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Txagorritxu" are 49 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Txagorritxu". 1 are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Hospital Txagorritxu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Txagorritxu, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 7 trials that are defined as “Not Applicable".